Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Remme

Showing results (21-30 of 236) with videos related to

Pageof 24
Sort By:
Cardiovascular Drugs and Therapy|August 6, 2008
Beta-blockade as first-line therapy in the elderly heart failure patient--the proper approach or asking for trouble?Willem J Remme
Cardiovascular Drugs and Therapy|July 19, 2005
Do standardized beta-blocker titration protocols in heart failure improve compliance? The GESICA registry experienceWillem J Remme
Journal of Cardiovascular Pharmacology|January 1, 1986
Congestive heart failure--pathophysiology and medical treatmentW J Remme
Cardiovascular Drugs and Therapy|June 1, 1989
Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitationsW J Remme
European Heart Journal|July 4, 1998
The sympathetic nervous system and ischaemic heart diseaseW J Remme
European Heart Journal|March 31, 1998
Prevention of worsening heart failure: future focusW J Remme
Heart Failure Clinics|March 28, 2007
Could beta-blockers precede or replace angiotensin-converting enzyme inhibitors in heart failure?Willem J Remme
Cardiovascular Drugs and Therapy|April 16, 2011
Cardiovascular Drugs and Therapy celebrates its 25th year of publication with a new section: education in cardiovascular therapyWillem J Remme
European Heart Journal|November 20, 1998
Towards the better treatment of heart failureW J Remme
European Heart Journal|October 31, 1998
Effect of ACE inhibition on neurohormonesW J Remme
Pageof 24

Showing results (21-30 of 236) with videos related to

Sort By:
Pageof 24
Cardiovascular Drugs and Therapy|August 6, 2008
Beta-blockade as first-line therapy in the elderly heart failure patient--the proper approach or asking for trouble?Willem J Remme
Cardiovascular Drugs and Therapy|July 19, 2005
Do standardized beta-blocker titration protocols in heart failure improve compliance? The GESICA registry experienceWillem J Remme
Journal of Cardiovascular Pharmacology|January 1, 1986
Congestive heart failure--pathophysiology and medical treatmentW J Remme
Cardiovascular Drugs and Therapy|June 1, 1989
Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitationsW J Remme
European Heart Journal|July 4, 1998
The sympathetic nervous system and ischaemic heart diseaseW J Remme
European Heart Journal|March 31, 1998
Prevention of worsening heart failure: future focusW J Remme
Heart Failure Clinics|March 28, 2007
Could beta-blockers precede or replace angiotensin-converting enzyme inhibitors in heart failure?Willem J Remme
Cardiovascular Drugs and Therapy|April 16, 2011
Cardiovascular Drugs and Therapy celebrates its 25th year of publication with a new section: education in cardiovascular therapyWillem J Remme
European Heart Journal|November 20, 1998
Towards the better treatment of heart failureW J Remme
European Heart Journal|October 31, 1998
Effect of ACE inhibition on neurohormonesW J Remme
Pageof 24